Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: A review

Vaccine

Volumn 30, Issue 24, 2012, Pages 3503-3514

  Jauneikaite, E ^a,b   Jefferies, J M ^a,c,d   Hibberd, M L ^b   Clarke, S C ^a,c,d  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c University Hospital Southampton NHS Foundation Trust   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Pneumococcal infections; Pneumococcal vaccine; Serotype; South East Asia; Streptococcus pneumoniae

Indexed keywords

BACTERIUM ISOLATE; BRUNEI DARUSSALAM; CAMBODIA; HUMAN; INDONESIA; LAOS; MYANMAR; NONHUMAN; PHILIPPINES; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; SEROTYPE; SINGAPORE; STREPTOCOCCUS PNEUMONIAE; SYSTEMATIC REVIEW; THAILAND; VIET NAM;

ASIA, SOUTHEASTERN; HEALTH POLICY; HUMANS; IMMUNIZATION SCHEDULE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84860990262     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.066     Document Type: Review

References (65)

1. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009, 374(September (9693)):893-902.
2. WHO. World Health Organisation. Available from: [cited 23.05.11]. http://www.who.int/nuvi/pneumococcus/en/.
3. Feikin D.R., Klugman K.P., Facklam R.R., Zell E.R., Schuchat A., Whitney C.G. Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin Infect Dis 2005, 41(August (4)):481-487.
4. Park I.H., Pritchard D.G., Cartee R., Brandao A., Brandileone M.C., Nahm M.H. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 2007, 45(April (4)):1225-1233.
5. Park I.H., Park S., Hollingshead S.K., Nahm M.H. Genetic basis for the new pneumococcal serotype, 6C. Infect Immun 2007, 75(September (9)):4482-4489.
6. Jin P., Kong F., Xiao M., Oftadeh S., Zhou F., Liu C., et al. First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J Infect Dis 2009, 200(November (9)):1375-1380.
7. Henrichsen J. Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 1995, 33(October (10)):2759-2762.
8. Johnson H.L., Deloria-Knoll M., Levine O.S., Stoszek S.K., Freimanis Hance L., Reithinger R., et al. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010, 7(October (10)).
9. Joffe M.D., Alpern E.R. Occult pneumococcal bacteremia: a review. Pediatr Emerg Care 2010, 26(June (6)):448-454. quiz 55-7.
10. Hausdorff W.P. Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur J Pediatr 2002, 161(December (Suppl. 2)):S135-S139.
11. Hausdorff W.P., Bryant J., Paradiso P.R., Siber G.R. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use. Part I. Clin Infect Dis 2000, 30(January (1)):100-121.
12. Pneumococcal conjugate vaccine for childhood immunization-WHO position paper Wkly Epidemiol Rec 2007, 82(March (12)):93-104.
13. Pandya G.A., McEllistrem M.C., Venepally P., Holmes M.H., Jarrahi B., Sanka R., et al. Monitoring the long-term molecular epidemiology of the pneumococcus and detection of potential 'vaccine escape' strains. PLoS One 2011, 6(1):e15950.
14. Hanage W.P., Finkelstein J.A., Huang S.S., Pelton S.I., Stevenson A.E., Kleinman K., et al. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics 2010, 2(June (2)):80-84.
15. Brueggemann A.B., Pai R., Crook D.W., Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog 2007, 3(November (11)):e168.
16. CDC Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR 2010, 59(34):1102-1106.
17. HPA. Pneumococcal vaccination recommendations. Available from: [cited 25.08.11]. http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Pneumococcal/GuidelinesPneumococcal/pneumoRecommendations/.
18. Scheifele D., Halperin S., Pelletier L., Talbot J. Invasive pneumococcal infections in Canadian children, 1991-1998: implications for new vaccination strategies. Canadian Paediatric Society/Laboratory Centre for Disease Control Immunization Monitoring Program, Active (IMPACT). Clin Infect Dis 2000, 31(July (1)):58-64.
19. Robinson K.A., Baughman W., Rothrock G., Barrett N.L., Pass M., Lexau C., et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001, 285(April (13)):1729-1735.
20. CDC Progress in introduction of pneumococcal conjugate vaccine-worldwide, 2000-2008. MMWR 2008, 57(42):1148-1151.
21. Hausdorff W.P., Bryant J., Kloek C., Paradiso P.R., Siber G.R. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use. Part II. Clin Infect Dis 2000, 30(January (1)):122-140.
22. Lin T.Y., Shah N.K., Brooks D., Garcia C.S. Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region. Vaccine 2010, (August).
23. Vasoo S., Singh K., Chow C., Lin R.T., Hsu L.Y., Tambyah P.A. Pneumococcal carriage and resistance in children attending day care centers in Singapore in an early era of PCV-7 uptake. J Infect 2010, 60(June (6)):507-509.
24. ANSORP. Asian network for surveillance of resistant pathogens. Available from: [cited 12.03.12]. http://www.ansorp.org/06_ansorp/ansorp_01.htm.
25. Isaacman D.J., McIntosh E.D., Reinert R.R. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 2010, 14(March (3)):e197-e209.
26. McIntosh E.D., Fritzell B., Fletcher M.A. Burden of paediatric invasive pneumococcal disease in Europe, 2005. Epidemiol Infect 2007, 135(May (4)):644-656.
27. ASEAN. Association of South East Asian Nations. Available from: [cited 20.06.11]. http://www.aseansec.org/18619.htm.
28. Moore C.E., Sengduangphachanh A., Thaojaikong T., Sirisouk J., Foster D., Phetsouvanh R., et al. Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid. Am J Trop Med Hyg 2010, 83(September (3)):451-457.
29. Jamal F., Pit S., Isahak I., Abdullah N., Zainal Z., Abdullah R., et al. Pneumococcal infection in hospitalized patients: a four-year study in Malaysia. Southeast Asian J Trop Med Public Health 1987, 18(March (1)):79-84.
30. Rohani M.Y., Raudzah A., Ng A.J., Ng P.P., Zaidatul A.A., Asmah I., et al. Epidemiology of Streptococcus pneumoniae infection in Malaysia. Epidemiol Infect 1999, 122(February (1)):77-82.
31. Rohani M.Y., Zin N.M., Hussin A., Nawi S.H., Hanapiah S.M., Wahab Z.A., et al. Current trend of pneumococcal serotypes distribution and antibiotic susceptibility pattern in Malaysian hospitals. Vaccine 2011, 29(August (34)):5688-5693.
32. Le C.F., Palanisamy N.K., Mohd Yusof M.Y., Sekaran S.D. Capsular serotype and antibiotic resistance of Streptococcus pneumoniae isolates in Malaysia. PLoS One 2011, 6(5):e19547.
33. Capeding M.R., Sombrero L.T., Lucero M.G., Saniel M.C. Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Filipino children. J Infect Dis 1994, 169(February (2)):479-480.
34. Kim S.W., Capeding M.R., Sombrero L., Kim S.H., Kilgore P.E., Herrera G. Serotype distribution of invasive S. pneumoniae in filipino children. 6th international symposium on pneumococci and pneumococcal diseases 2008.
35. Bravo L.C., Gonzales M.L.A., Lim A.O., Gray S., Kim S.A., Kilgore P.E., et al. Active hospital-based epidemioloogical surveillance to estimate the burden of invasive pneumococcal disease (IPD) in children in Metro Manila, Philippines. 7th international symposium on pneumococci and pneumococcal diseases 2010.
36. Madrid M.A., Santos J., Banez M.A.P., Gotos L.C., Gray S., Brooks D., et al. Active hospital-based epidemiological surveillance of invasive penumococcal disease (IPD) in children in Metro Manila, Philippines. 7th international symposium on penumococci and pneumococcal diseases 2010.
37. Lupisan S.P., Herva E., Sombrero L.T., Quiambao B.P., Capeding M.R., Abucejo P.E., et al. Invasive bacterial infections of children in a rural province in the central Philippines. Am J Trop Med Hyg 2000, 62(March (3)):341-346.
38. Soh S.W., Poh C.L., Lin R.V. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from pediatric patients in Singapore. Antimicrob Agents Chemother 2000, 44(August (8)):2193-2196.
39. Hsu L.Y., Lui S.W., Lee J.L., Hedzlyn H.M., Kong D.H., Shameen S., et al. Adult invasive pneumococcal disease pre- and peri-pneumococcal conjugate vaccine introduction in a tertiary hospital in Singapore. J Med Microbiol 2009, 58(January (Pt 1)):101-104.
40. Chong C.Y., Koh-Cheng T., Yee-Hui M., Nancy T.W. Invasive pneumococcal disease in Singapore children. Vaccine 2008, 26(June (27-28)):3427-3431.
41. Jefferies J.M., Tee W.S., Clarke S.C. Molecular analysis of Streptococcus pneumoniae clones causing invasive disease in children in Singapore. J Med Microbiol 2011, 60(June (Pt 6)):750-755.
42. Srifeungfung S., Tribuddharat C., Comerungsee S., Chatsuwan T., Treerauthanaweeraphong V., Rungnobhakhun P., et al. Serotype coverage of pneumococcal conjugate vaccine and drug susceptibility of Streptococcus pneumoniae isolated from invasive or non-invasive diseases in central Thailand, 2006-2009. Vaccine 2010, 28(April (19)):3440-3444.
43. Phongsamart W., Srifeungfung S., Dejsirilert S., Chatsuwan T., Nunthapisud P., Treerauthaweeraphong V., et al. Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000-2005. Vaccine 2007, 25(January (7)):1275-1280.
44. Baggett H.C., Peruski L.F., Olsen S.J., Thamthitiwat S., Rhodes J., Dejsirilert S., et al. Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand. Clin Infect Dis 2009, 48(March (Suppl. 2)):S65-S74.
45. Techasansiri C., Dejsirilert S., Sirinavin S., Sawanpanyalert P., Saengsuk L., Polwichai P., et al. A nationwide study on serotypes of invasive strains of pneumococcus in Thailand, 1998-2008. 7th international symposium on pneumococcal diseases 2010.
46. Suwanpakdee D., Samakoses R., Sirinavin S., Kerdpanich A., Simasathien S., Thunyaharn S., et al. Invasive pneumococcal disease in Phramongkutklao Hospital 2004-2008: clinical data, serotype distribution and antimicrobial resistance patterns. J Med Assoc Thai 2010, 93(November (Suppl. 5)):S40-S45.
47. Levine S., Dejsirilert S., Sangsuk L., Chantra S., Feikin D.R., Dowell S.F., et al. Serotypes and antimicrobial resistance of streptococcus pneumoniae in Thailand 2002-2004. Pediatr Infect Dis J 2006, 25(February (2)):176-178.
48. Srifeungfung S., Chokephaibulkit K., Tribuddharat C. Serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae isolated from hospitalized patients in Thailand. Southeast Asian J Trop Med Public Health 2007, 38(May (3)):469-477.
49. Parry C.M., Duong N.M., Zhou J., Mai N.T., Diep T.S., Thinh le Q., et al. Emergence in Vietnam of Streptococcus pneumoniae resistant to multiple antimicrobial agents as a result of dissemination of the multiresistant Spain(23F)-1 clone. Antimicrob Agents Chemother 2002, 46(November (11)):3512-3517.
50. Song J.H., Lee N.Y., Ichiyama S., Yoshida R., Hirakata Y., Fu W., et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis 1999, 28(June (6)):1206-1211.
51. Song J.H., Jung S.I., Ko K.S., Kim N.Y., Son J.S., Chang H.H., et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004, 48(June (6)):2101-2107.
52. Kim S.H., Song J.H., Chung D.R., Thamlikitkul V., Yang Y., Wang H., et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Antimicrob Agents Chemother 2012, 56(March (3)):1418-1426.
53. Theodoratou E., Johnson S., Jhass A., Madhi S.A., Clark A., Boschi-Pinto C., et al. The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. Int J Epidemiol 2010, 39(April (Suppl. 1)):i172-i185.
54. Dang D.A., Nguyen H.A., Nyambat B., Paul K., Huong V.T.T., Yosida L.M., et al. Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolates among children under 5 years of age, Hai Phong City, Vietnam, July 2006-October 2007. 6th international symposium on pneumococci and pneumococcal diseases 2008.
55. CDC. PCR deduction of pneumococcal serotypes. Available from: [cited 08.07.11]. http://www.cdc.gov/ncidod/biotech/strep/pcr.htm.
56. Lu C.Y., Santosham M. Survey of national immunization programs and vaccine coverage rates in Asia Pacific countries. Vaccine 2012, 30(March (13)):2250-2255.
57. Baggett H.C., Peruski L.F., Olsen S.J., Thamthitiwat S., Rhodes J., Dejsirisert S., et al. Incidence of pneumococcal bacteremia requiring hospitalization in rural Thailand. 6th international symposium on pneumococci and pneumococcal diseases 2008.
58. Prymula R., Chlibek R., Ivaskeviciene I., Mangarov A., Meszner Z., Perenovska P., et al. Paediatric pneumococcal disease in Central Europe. Eur J Clin Microbiol Infect Dis 2011, 30(November (11)):1311-1320.
59. Yao K.H., Wang L.B., Zhao G.M., Zheng Y.J., Deng L., Huang J.F., et al. Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia. Vaccine 2011, 29(March (12)):2296-2301.
60. Zhang B., Gertz R.E., Liu Z., Li Z., Fu W., Beall B. Characterization of highly antimicrobial-resistant clinical pneumococcal isolates recovered in a Chinese hospital during 2009-2010. J Med Microbiol 2012, 61(January (Pt 1)):42-48.
61. Farrell D.J., Klugman K.P., Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J 2007, 26(February (2)):123-128.
62. Alexandre C., Dubos F., Courouble C., Pruvost I., Varon E., Martinot A. Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement. Acta Paediatr 2010, 99(November (11)):1686-1690.
63. Moxon E.R., Siegrist C.A. The next decade of vaccines: societal and scientific challenges. Lancet 2011, 378(July (9788)):348-359.
64. Pneumococcal conjugate vaccines in Asia and the Pacific. Singapore, 9-11 October 2000. Report of an Asia Pacific Board Advisory Meeting. Vaccine 2001, 19(September (32)):4579-4587.
65. GAVI. The global alliance for vaccines and immunization. Available from: [cited 08.07.11]. http://www.gavialliance.org/.